Drug Patents containing Lidocaine Hydrochloride

Lidocaine Hydrochloride Patents

Given below is the list of patents protecting Lidocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Akten	US8759401	Aqueous gel formulation and method for inducing topical anesthesia	Jul 24, 2026	Thea Pharma
Zingo	US5630796	Method of delivering powder transdermally with needless injector	May 20, 2014 (Expired)	Powder Pharms
Zingo	US5899880	Needleless syringe using supersonic gas flow for particle delivery	May 04, 2016 (Expired)	Powder Pharms
Zingo	US6004286	Particle delivery	Mar 17, 2017 (Expired)	Powder Pharms
Zingo	US6881200	Needleless syringe using super sonic gas flow for particle delivery	Jun 11, 2016 (Expired)	Powder Pharms
Zingo	US8540665	Particle cassettes and processes therefor	Oct 22, 2029	Powder Pharms
Zingo	US9358338	Particle cassettes and processes therefor	Apr 27, 2035	Powder Pharms
Zingo	US9370622	Devices and methods for delivering particles	Sep 28, 2035	Powder Pharms

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lidocaine Hydrochloride's patents.

Latest Legal Activities on Lidocaine Hydrochloride's Patents

Given below is the list recent legal activities going on the following patents of Lidocaine Hydrochloride.

Event	Date	Patent/Publication

Maintenance Fee Reminder Mailed	12 Feb, 2024	US9370622
Payment of Maintenance Fee, 8th Yr, Small Entity	05 Mar, 2021	US8540665
Payment of Maintenance Fee, 4th Yr, Small Entity	03 Jul, 2019	US9370622
Recordation of Patent Grant Mailed	21 Jun, 2016	US9370622
Patent Issue Date Used in PTA Calculation	21 Jun, 2016	US9370622
Issue Notification Mailed	01 Jun, 2016	US9370622
Dispatch to FDC	24 May, 2016	US9370622
Application Is Considered Ready for Issue	20 May, 2016	US9370622
Issue Fee Payment Verified	20 May, 2016	US9370622
Issue Fee Payment Received	20 May, 2016	US9370622

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Lidocaine Hydrochloride Generics

Several generic applications have been filed for Lidocaine Hydrochloride. The first generic version for Lidocaine Hydrochloride was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by The J Molner Co Ou and was approved on Apr 29, 2024.

Given below is the list of companies who have filed for Lidocaine Hydrochloride generic.

1. TARO

Taro Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	solution	Prescription	TOPICAL	AT	Dec 7, 2023

2. BEL MAR

Bel Mar Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bel Mar.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

3. HUONS

Huons Co Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Huons.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	May 7, 2020
2%	injectable	Prescription	INJECTION	AP	Jun 15, 2023

4. THE J MOLNER

The J Molner Co Ou has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by The J Molner.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	solution	Prescription	TOPICAL	AT	Apr 29, 2024

5. ASPIRO

Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Nov 8, 2021
2%	injectable	Prescription	INJECTION	AP	Dec 13, 2023

6. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cosette.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	jelly	Discontinued	TOPICAL	N/A	Apr 29, 1993

7. LANNETT CO INC

Lannett Co Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	solution	Prescription	TOPICAL	AT	Feb 27, 2007

8. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	injectable	Prescription	INJECTION	AP	Oct 30, 2017
1%	injectable	Prescription	INJECTION	AP	Oct 30, 2017

9. PAI HOLDINGS PHARM

Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Out of these 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	solution	Prescription	TOPICAL	AT	Mar 12, 2014
2%	solution	Prescription	ORAL	AT	Feb 20, 2024

10. EXTROVIS

Extrovis Ag has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Extrovis.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	injectable	Discontinued	INJECTION	N/A	Sep 27, 2010

11. GD SEARLE LLC

Gd Searle Llc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Gd Searle Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

12. WATSON LABS INC

Watson Laboratories Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	jelly	Discontinued	TOPICAL	N/A	Mar 23, 2011

13. PHARMATON

Pharmaton Ltd has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name LIDOCATON. Given below are the details of the strengths of this generic introduced by Pharmaton.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	injectable	Discontinued	INJECTION	N/A	Aug 17, 1983

14. WYETH AYERST

Wyeth Ayerst Laboratories has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wyeth Ayerst.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

15. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Out of these 1% version comes by the name LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Hikma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Approved Prior to Jan 1, 1982
2%	solution	Discontinued	ORAL	N/A	Jul 10, 1995
4% (reference standard)	solution	Prescription	TOPICAL	AT	Apr 3, 1985

16. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

17. SINTETICA US

Sintetica Us Llc has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sintetica Us.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	injectable	Prescription	INJECTION	AP	May 5, 2022
2%	injectable	Prescription	INJECTION	AP	Sep 19, 2022
1%	injectable	Prescription	INJECTION	AP	Sep 19, 2022

18. AFAXYS

Afaxys Pharma Llc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Afaxys.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Jun 9, 2022

19. INTL MEDICATION

International Medication Systems Ltd has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Out of these 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS, 4% version comes by the name LARYNG-O-JET KIT. Given below are the details of the strengths of this generic introduced by Intl Medication.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Approved Prior to Jan 1, 1982
2%	solution	Discontinued	ORAL	N/A	Feb 2, 1982
4%	solution	Prescription	TOPICAL	AT	Approved Prior to Jan 1, 1982

20. CARLISLE

Carlisle Laboratories Inc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name ALPHACAINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Carlisle.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

21. DELL LABS

Dell Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dell Labs.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

22. ELKINS SINN

Elkins Sinn Div Ah Robins Co Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Elkins Sinn.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
0.5%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

23. KENDALL IL

Kendall Co has filed for 1 generic for Lidocaine Hydrochloride. This 4% version comes by the name LARYNGOTRACHEAL ANESTHESIA KIT. Given below are the details of the strengths of this generic introduced by Kendall Il.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	solution	Discontinued	TOPICAL	N/A	Jun 10, 1983

24. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Approved Prior to Jan 1, 1982
2%	injectable	Prescription	INJECTION	AP	Approved Prior to Jan 1, 1982

25. MILES

Miles Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Miles.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

26. BIONPHARMA

Bionpharma Inc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name ANESTACON. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	jelly	Discontinued	TOPICAL	N/A	Approved Prior to Jan 1, 1982

27. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	solution	Prescription	ORAL	AT	Nov 18, 1982
4%	solution	Prescription	TOPICAL	AT	Nov 18, 1982

28. LUITPOLD

Luitpold Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Luitpold.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

29. BELMORA LLC

Belmora Llc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Belmora Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

30. AM REGENT

American Regent Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Aug 14, 2015

31. ABRAXIS PHARM

Abraxis Pharmaceutical Products has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
1.5%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

32. SENTISS

Sentiss Ag has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sentiss.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	jelly	Prescription	TOPICAL	AT	Feb 12, 2003

33. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Out of these 1% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Jul 24, 1985
2%	injectable	Prescription	INJECTION	AP	Approved Prior to Jan 1, 1982

34. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name GLYDO. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2% (reference standard)	jelly	Prescription	TOPICAL	AT	Apr 28, 2014

35. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	solution	Prescription	TOPICAL	AT	Mar 23, 2022

36. RUBICON

Rubicon Research Private Ltd has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2% (reference standard)	solution	Prescription	ORAL	AT	Mar 28, 2023

37. PACO

Paco Research Corp has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Paco.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
4%	solution	Discontinued	TOPICAL	N/A	Jun 30, 1989

38. B BRAUN MEDICAL INC

B Braun Medical Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by B Braun Medical Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Aug 3, 2018

39. RISING

Rising Pharma Holding Inc has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
0.5%	injectable	Discontinued	INJECTION	N/A	Dec 8, 2010
1%	injectable	Discontinued	INJECTION	N/A	Dec 8, 2010
2%	injectable	Discontinued	INJECTION	N/A	Apr 11, 2014

40. LYPHOMED

Lyphomed Div Fujisawa Usa Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lyphomed.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

41. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	solution	Discontinued	ORAL	N/A	Approved Prior to Jan 1, 1982

42. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
2%	solution	Prescription	ORAL	AT	Feb 27, 2007

43. HOSPIRA

Hospira Inc has filed for 10 different strengths of generic version for Lidocaine Hydrochloride. Out of these 1% version comes by the name LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, 1.5% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, 4% version comes by the name LTA II KIT, 2% version comes by the name LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, 20% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, 200mg/100ml version comes by the name LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%, 400mg/100ml version comes by the name LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%, 5% version comes by the name LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, 0.5% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, 10% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Hospira.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Sep 28, 1998
1.5%	injectable	Discontinued	INJECTION	N/A	Jul 31, 1984
4%	solution	Discontinued	TOPICAL	N/A	Jul 31, 1984
2%	injectable	Prescription	INJECTION	AP	Sep 28, 1998
20%	injectable	Discontinued	INJECTION	N/A	Jul 31, 1984
200MG/100ML	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
400MG/100ML	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
5% (reference standard) (reference listed drug)	injectable	Prescription	SPINAL	N/A	Approved Prior to Jan 1, 1982
0.5%	injectable	Prescription	INJECTION	AP	Jul 31, 1984
10%	injectable	Discontinued	INJECTION	N/A	Jul 31, 1984

44. EPIC PHARMA LLC

Epic Pharma Llc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982
2%	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

45. MANKIND PHARMA

Mankind Pharma Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Nov 29, 2023
2%	injectable	Prescription	INJECTION	AP	Jul 11, 2023

46. SPECTRA MDCL DEVICES

Spectra Medical Devices Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Spectra Mdcl Devices.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
1%	injectable	Prescription	INJECTION	AP	Apr 18, 2018

47. ABBOTT

Abbott Laboratories Hosp Products Div has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Out of these 2% version comes by the name PEDIATRIC LTA KIT. Given below are the details of the strengths of this generic introduced by Abbott.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
10%	injectable	Discontinued	INJECTION	N/A	Feb 2, 1983
2%	solution	Discontinued	TOPICAL	N/A	Jul 31, 1984
20%	injectable	Discontinued	INJECTION	N/A	May 25, 1988